These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29052160)

  • 21. Estimation of a Preference-Based Summary Score for the Patient-Reported Outcomes Measurement Information System: The PROMIS
    Dewitt B; Feeny D; Fischhoff B; Cella D; Hays RD; Hess R; Pilkonis PA; Revicki DA; Roberts MS; Tsevat J; Yu L; Hanmer J
    Med Decis Making; 2018 Aug; 38(6):683-698. PubMed ID: 29944456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Identification, Review and Synthesis of Health State Utility Values from the Literature.
    Ara R; Brazier J; Peasgood T; Paisley S
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):43-55. PubMed ID: 29052156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping the EORTC-QLQ-C30 to the EQ-5D-3L: An Assessment of Existing and Newly Developed Algorithms.
    Woodcock F; Doble B;
    Med Decis Making; 2018 Nov; 38(8):954-967. PubMed ID: 30226101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients.
    Paracha N; Abdulla A; MacGilchrist KS
    Health Qual Life Outcomes; 2018 Sep; 16(1):179. PubMed ID: 30208899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Models based on value and probability in health improve shared decision making.
    Ortendahl M
    J Eval Clin Pract; 2008 Oct; 14(5):714-7. PubMed ID: 19018900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review.
    Paracha N; Thuresson PO; Moreno SG; MacGilchrist KS
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):549-559. PubMed ID: 27574879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies.
    Ara R; Brazier J; Young T
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):67-75. PubMed ID: 29052159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility-Based Instruments for People with Dementia: A Systematic Review and Meta-Regression Analysis.
    Li L; Nguyen KH; Comans T; Scuffham P
    Value Health; 2018 Apr; 21(4):471-481. PubMed ID: 29680105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury: A Systematic Review and Mapping Study.
    Ward Fuller G; Hernandez M; Pallot D; Lecky F; Stevenson M; Gabbe B
    Value Health; 2017 Jan; 20(1):141-151. PubMed ID: 28212955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient preference-based treatment thresholds and recommendations: a comparison of decision-analytic modeling with the probability-tradeoff technique.
    Man-Son-Hing M; Laupacis A; O'Connor AM; Coyle D; Berquist R; McAlister F
    Med Decis Making; 2000; 20(4):394-403. PubMed ID: 11059472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping PROMIS Global Health Items to EuroQol (EQ-5D) Utility Scores Using Linear and Equipercentile Equating.
    Thompson NR; Lapin BR; Katzan IL
    Pharmacoeconomics; 2017 Nov; 35(11):1167-1176. PubMed ID: 28710740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple-attribute group decision making with different formats of preference information on attributes.
    Xu Z
    IEEE Trans Syst Man Cybern B Cybern; 2007 Dec; 37(6):1500-11. PubMed ID: 18179069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review of health state utility values for economic evaluation of colorectal cancer.
    Jeong K; Cairns J
    Health Econ Rev; 2016 Dec; 6(1):36. PubMed ID: 27541298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly.
    Badia X; Trainer P; Biermasz NR; Tiemensma J; Carreño A; Roset M; Forsythe A; Webb SM
    J Med Econ; 2018 Apr; 21(4):382-389. PubMed ID: 29261359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.
    Kalaitzakis E; Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kontodimopoulos N
    Qual Life Res; 2016 Apr; 25(4):947-57. PubMed ID: 26471264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.